The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMoneysupermarket.Com Regulatory News (MONY)

Share Price Information for Moneysupermarket.Com (MONY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.80
Bid: 216.00
Ask: 216.40
Change: 2.00 (0.94%)
Spread: 0.40 (0.185%)
Open: 210.00
High: 217.20
Low: 210.00
Prev. Close: 213.80
MONY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Results

18 Apr 2023 07:00

RNS Number : 4809W
Moneysupermarket.com Group PLC
18 April 2023
 

18 April 2023

Q1 2023 trading update

Moneysupermarket.com Group PLC reports trading results for the quarter ended 31 March 2023

Strong trading performance supported by recovery in Insurance and Travel

Revenue

Q1 2023

Q1 2022

Growth

£m

£m

%

Insurance

50.6

41.1

23

Money

26.9

24.8

9

Home Services

9.6

9.1

5

Travel

5.4

3.3

63

Cashback

15.1

14.6

3

Inter-vertical eliminations

(1.2)

(0.6)

n.m.

Total

106.3

92.3

15

 

· One year after the introduction of the FCA General Insurance pricing regulations which significantly reduced the market in Q1 2022, car has recovered strongly supported by double-digit growth in market switching volumes. Travel insurance also grew with revenue at c.50% above 2019 levels.

· Money growth reflected strong promotional offers in banking, although this was partially offset by the continuing weakness in borrowing conversion, particularly in loans.

· Home Services performance benefitted from attractive mobile offers. Whilst we launched our first fixed energy tariff since October 2021 at the end of March, it was a limited size collective deal that will have no material impact on revenue. We still do not expect a significant energy switching market in 2023.

· Travel grew strongly as the sector continues to recover.

· In Cashback, good growth in travel offset lower activity in other channels amid the weaker consumer spending environment.

Outlook

The factors affecting our markets are unchanged from those outlined in our preliminary results in February. The Board continues to be confident of delivering market expectations for the year.

Peter Duffy, CEO of Moneysupermarket Group, said:

"This is a strong performance led by recovery in Insurance and Travel. Our strategy of making it easier for people to save on more of their bills is going well and means we're helping consumers cope with cost of living pressures."

 

Notes:

The new inter-vertical eliminations revenue line reflects transactions where revenue in Cashback and Travel has also been recorded as cost of sales in other verticals. 2022 comparatives table restated on the same basis.

Market expectations of adjusted EBITDA for 2023 from the analyst consensus on our investor website are in a range of £121.1m to £129.2m, with an average of £124.8m.

For further information, contact:

Niall McBride, Chief Financial Officer niall.mcbride@moneysupermarket.com / 0203 826 4700

Alvaro Aguilar, Strategy & IR Director alvaro.aguilar@moneysupermarket.com / 0203 846 2760

Ronke Fadipe, IR Manager ronke.fadipe@moneysupermarket.com / 0203 846 2434

William Clutterbuck, H/Advisors Maitland wclutterbuck@h-advisors.global / 07785 292617

 

This statement may include statements that are forward looking in nature. Forward looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Group to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Except as required by the Listing Rules, Disclosure Guidance and Transparency Rules and applicable law, the Group undertakes no obligation to update, revise or change any forward-looking statements to reflect events or developments occurring after the date such statements are published. The information in this release is based on management information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTIRMATMTTBBFJ
Date   Source Headline
16th Apr 202410:52 amRNSQ1 2024 Update REPLACE
16th Apr 20247:00 amRNSQ1 2024 Update
8th Apr 20242:46 pmRNSDirector/PDMR Shareholding
5th Apr 202411:42 amRNSDirector/PDMR Shareholding
5th Apr 202411:40 amRNSDirector/PDMR Shareholding
2nd Apr 202410:57 amRNSDirector/PDMR Shareholding
2nd Apr 202410:42 amRNSDirector/PDMR Shareholding
28th Mar 20244:30 pmRNSTotal Voting Rights
21st Mar 202412:45 pmRNSDirectorate Change
18th Mar 20243:55 pmRNSHolding(s) in Company
7th Mar 20241:19 pmRNSDirector/PDMR Shareholding
4th Mar 20249:00 amRNSAnnual Financial Report
1st Mar 20247:00 amRNSHolding(s) in Company
29th Feb 20244:30 pmRNSTotal Voting Rights
22nd Feb 202412:24 pmRNSHolding(s) in Company
22nd Feb 202412:15 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSPreliminary Results
7th Feb 202410:23 amRNSDirector/PDMR Shareholding
31st Jan 20244:30 pmRNSTotal Voting Rights
8th Jan 20242:19 pmRNSDirector/PDMR Shareholding
29th Dec 20231:00 pmRNSTotal Voting Rights
7th Dec 20231:05 pmRNSDirector/PDMR Shareholding
30th Nov 20234:30 pmRNSTotal Voting Rights
7th Nov 202310:51 amRNSDirector/PDMR Shareholding
1st Nov 202311:18 amRNSHolding(s) in Company
31st Oct 20234:30 pmRNSTotal Voting Rights
17th Oct 20237:00 amRNSQ3 2023 Update
16th Oct 20234:40 pmRNSDirector/PDMR Shareholding
13th Oct 20238:00 amRNSAdditional Listing
6th Oct 202310:58 amRNSDirector/PDMR Shareholding
7th Sep 202312:56 pmRNSDirector/PDMR Shareholding
31st Aug 20234:30 pmRNSTotal Voting Rights
29th Aug 202310:26 amRNSHolding(s) in Company
11th Aug 20238:48 amRNSHolding(s) in Company
7th Aug 202311:46 amRNSDirector/PDMR Shareholding
7th Aug 20238:53 amRNSHolding(s) in Company
1st Aug 20239:00 amRNSBlock listing Interim Review
31st Jul 20234:30 pmRNSTotal Voting Rights
27th Jul 202311:32 amRNSHolding(s) in Company
24th Jul 20237:00 amRNSInterim Results to 30 June 2023
7th Jul 202310:59 amRNSDirector/PDMR Shareholding
30th Jun 20234:30 pmRNSTotal Voting Rights
21st Jun 202310:00 amRNSDirectorate Change
8th Jun 20239:34 amRNSDirector/PDMR Shareholding
31st May 20234:30 pmRNSTotal Voting Rights
12th May 20233:26 pmRNSDirector/PDMR Shareholding
12th May 202311:29 amRNSDirector/PDMR Shareholding
9th May 20232:00 pmRNSDirector/PDMR Shareholding
4th May 202310:55 amRNSResult of AGM
28th Apr 20234:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.